NCT03957954View on ClinicalTrials.gov

Stem Cell Therapy for Limbal Stem Cell Deficiency

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

January 31, 2027

Study Completion Date

April 30, 2027

Conditions
Limbal Stem-cell Deficiency
Interventions
BIOLOGICAL

cLSC

Transplantation of cLSC

DEVICE

Scleral contact lens (SCL)

Scleral contact lens device (SCL) will be used to stabilize and improve ocular surface.

Trial Locations (1)

90095

RECRUITING

University of California, Los Angeles

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

collaborator

California Institute for Regenerative Medicine (CIRM)

OTHER

lead

University of California, Los Angeles

OTHER

NCT03957954 - Stem Cell Therapy for Limbal Stem Cell Deficiency | Biotech Hunter | Biotech Hunter